Objective: This study was undertaken to determine if automated differential leukocyte counts (A-DIFF) can be used in place of manual differential leukocyte counts (M-DIFF) in chronic lymphocytic leukemia (CLL) patients.
Science
Automated differential leukocyte counts (A-DIFF) have been shown to be reliable substitutes for manual differential leukocyte counts (M-DIFF) in blood specimens containing mature forms of normal white cell populations in healthy subjects. [1] [2] [3] Blood specimens from diseased subjects, however, may or may not yield reliable A-DIFF due to the presence of immature forms of normal white cells and/ or abnormal white cells and are consequently flagged by the analyzer for verification of results by smear review and/ or a M-DIFF. [4] [5] [6] In contrast, the presence of mature forms of normal white cells but with abnormal morphology, such as smudge cells seen in smears of blood specimens from chronic lymphocytic leukemia (CLL) patients, often results in unreliable M-DIFF. [7] [8] [9] Smears prepared from ethylenediaminetetraacetic acid-(EDTA-) anticoagulated blood specimens drawn from CLL patients often reveal many smudge cells on microscopic examination. [7] [8] [9] The formation of smudge cells is believed to be an in vitro phenomenon occurring in the process of smear preparation, and it is attributed to fragility of the lymphoid cell population in CLL. [8] [9] Addition of a drop of 22% albumin to 4 or 5 drops of blood prior to preparation of the smear has been shown to markedly diminish or even eliminate smudge cell formation. [10] [11] [12] Consequently, it is a common practice in many laboratories, including ours, to report the results of M-DIFF performed on albuminized blood smears whenever the initial (non-albuminized) smear reveals many smudge cells. [7] [8] The process of albuminization of blood and performing a M-DIFF on the albuminized smear after examining the initial non-albuminized smear under the microscope is time consuming. Therefore, we decided to determine if A-DIFF can be used in place of M-DIFF in these cases. Since the smudge cell formation involves primarily or only lymphocytes, which also constitute the predominant WBC population in CLL patients, we chose to limit the study to comparison of automated vs manual lymphocyte counts.
Materials and Methods
Between September 11, 2006 , and August 31, 2010, we were able to collect from our laboratory's routine workload the CBC and differential leukocyte count (DIFF) data on a total of 133 specimens from 124 patients suspected of
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labmedicine.com CLL on the basis of blood smear review by a pathologist. The CBC and A-DIFF results were generated on Sysmex (Mundelein, IL) automated hematology analyzers (XE-2100 for the first 3 years and XE-5000 for the last year), which were calibrated and quality controlled according to the manufacturer's recommendations. [13] [14] The XE-2100 was replaced by XE-5000 in our laboratory at the time of the expiration of the lease of the former. Both models, however, use identical technology to generate CBC and A-DIFF results. The M-DIFF results were obtained by performing a 100-cell differential leukocyte count on handmade Wright-Giemsastained albuminized blood smears. With the knowledge that smudge cells most likely represent remnants of fragile lymphoid cells, we compared the results of relative percentage and absolute number of lymphocytes obtained by A-DIFF with the corresponding results obtained by M-DIFF on the albuminized blood smears. Usable data for comparative analysis of automated vs manual lymphocyte counts, both in percent (%) and in absolute number (#), were available on a total of 83 specimens from 76 patients in an age range of 46 to 94 years (45 males with a median age of 73 years, and 31 females with a median age of 77 years). The reasons for excluding specimens from analysis were as follows: (a) incomplete A-DIFF result excluding the percentage and absolute numbers of neutrophils, lymphocytes, and monocytes generated by the analyzer on 32 specimens; (b) CBC without DIFF performed as ordered by the clinician on 7 specimens; and (c) albuminized smear not made on 11 specimens because the nonalbuminized smear did not reveal any smudge cells or revealed only occasional (less than 10% of leukocytes) smudge cells. The presence of smudge cells was graded according to the criteria published by Gulati in Blood Cell Morphology Grading Guide. 15 An albuminized blood smear for manual DIFF is routinely prepared in our laboratory whenever the non-albuminized blood smear reveals 1+ or greater smudge cells (ie, 10% or greater). All of the 83 specimens from 76 patients included in the comparative analysis showed a variable degree of smudge cells ranging from 1+ to 4+ on the non-albuminized blood smears. Although not as a part of this study, additional studies, which included immunophenotypic analysis of peripheral blood by flow cytometry and/or bone marrow examination, were performed on 38 of the 76 patients and a diagnosis of either CD5+, CD20+ CLL; CD5-neg, CD20+ B-lymphoproliferative disorder; or T-lymphoproliferative disorder was confirmed on 31/38 cases, 6/38 cases, and 1/38 cases, respectively. The suspected diagnosis of CLL based on clinical judgment and/or CBC and DIFF findings on the remaining 38 patients remained unconfirmed because no additional workup was performed at the discretion of the patient's physician and/or the patient. The data analysis included comparison of raw data, calculation of means, and linear regression analysis using Excel software (Microsoft, Redmond, WA).
Results
Comparative raw data of automated vs manual lymphocyte counts, both in percent (relative) and in absolute numbers are tabulated in Table 1 and Table 2 , respectively. The mean relative lymphocyte count by automated method was 73.6% as compared to 75.6% by the manual method ( Table 1) . The mean absolute lymphocyte count by automated method was 32.1 × 10 3 /µL as opposed to 32.9 × 10 3 /µL by the manual method ( Table 2) . A linear regression analysis of the data on relative lymphocyte counts by the 2 methods yielded a correlation coefficient of 0.928 (Figure 1) . A slightly higher correlation coefficient of 0.998 was obtained when the absolute lymphocyte counts data was analyzed by linear regression (Figure 2) . 80  24  64  62  66  77  80  25  63  62  67  72  73  26  98  96  68  90  90  27  77  75  69  79  73  28  61  56  70  57  61  29  57  45  71  97  91  30  91  88  72  70  65  31  95  95  73  91  90  32  82  76  74  79  71  33  72  77  75  85  79  34  66  64  76  80  79  35  89  91  77  81  78  36  87  92  78  100  98  37  56  49  79  68  70  38  98  96  80  88  80  39  89  88  81  92  87  40  53  53  82  55  52  41  87  86  83  81  78  42  83 
Discussion
Comparative data analysis of relative lymphocyte counts in the range of 44% to 100% on a total of 83 specimens from 76 patients carrying a known or suspect diagnosis of CLL yielded a difference of only 2 percentage points between the means obtained by the 2 methods. Similarly, the analysis of absolute lymphocyte counts in the range of 5.1 × 10 3 /µL to 285.3 × 10 3 /µL generated a difference of only 0.8 × 10 3 /µL between the means obtained by the 2 methods. We consider these differences in the means obtained by the 2 methods for relative lymphocyte counts and absolute lymphocyte counts clinically insignificant. Furthermore, linear regression analysis of the data revealed an excellent correlation (an r 2 value of 0.928 or greater) between the 2 methods, for both, the relative lymphocyte counts and absolute lymphocyte counts. A number of published studies have revealed a good overall correlation between the A-DIFF and M-DIFF results obtained on blood specimens containing morphologically normal mature white cell subpopulations. [1] [2] [3] [4] [5] [6] Since CLL is generally associated with the findings of many smudge cells and morphologically normal other white cell subpopulations, our study extends the previously established accuracy of automated differential leukocytes counts in the general patient population to CLL patients. Based on the excellent correlation observed between the automated and the manual lymphocyte counts, coupled with the knowledge that smudge cells typically represent remnants of fragile lymphocytes in CLL patients, we are recommending that A-DIFF generated by the Sysmex hematology analyzers (XE2100 and XE5000 in particular) should be used in place of M-DIFF in patients either diagnosed with or suspected of having CLL. Our findings also support the "Good Practice Guidelines on the Reporting of Smudge Cells" proposed by the Hematology Committee of Quality Management ProgramLaboratory Services of Ontario, Canada. 17 along with a qualitative comment that smudge cells are present, and (b) if an A-DIFF is not available, counting smudge cells as lymphocytes with an associated qualitative comment or as a separate category within the M-DIFF. 9 Whether our observations can be extrapolated to automated lymphocyte counts generated by other automated analyzers, particularly those using different technology to generate differential leukocyte counts, remains to be determined. Since the presence of smudge cells in the peripheral blood smear is considered a characteristic finding and by some even as a prognostic marker if and when reported as a proportion of total lymphocyte population in CLL, 16 it is highly desirable that a non-albuminized blood smear be reviewed microscopically at the time of initial diagnosis and perhaps also periodically thereafter if and when used as a prognostic marker. LM
